This review summarizes the research on phospholipids and their use for drug delivery
related to the Phospholipid Research Center Heidelberg (PRC). The focus is on projects that …

The field of medical ultrasound has undergone a significant evolution since the development
of microbubbles as contrast agents. However, because of their size, microbubbles remain in …

Nanodroplets–emerging phase-changing sonoresponsive materials–have attracted
substantial attention in biomedical applications for both tumour imaging and therapeutic …

The evolution of ultrasonic contrast agents to enhance the reflectivity of structures in the
human body has consolidated ultrasound's stance as a reliable diagnostic imaging modality …

The structural complexity of the brain hinders the traditional treatment of brain diseases from
achieving desirable outcomes, which urges the research and development of multiple …

Microbubbles (MBs) have been shown to create transient or lethal pores in cell membranes
under the influence of ultrasound, known as ultrasound-mediated sonoporation. Several …

Ultrasound has been developed as both a diagnostic tool and a potent promoter of
beneficial bio-effects for the treatment of chronic bacterial infections. Bacterial infections …

Chemistry has long been playing its specific role in ultrasound-responsive theranostic
biomedicine in the form of microbubbles, which clinically provide the dynamic detection of …

Ultrasound with low frequency (20–100 kHz) assisted drug delivery has been widely
investigated as a non-invasive method to enhance the permeability and retention effect of …

Nanomedicine in oncology has not had the success in clinical impact that was anticipated in
the early stages of the field's development. Ideally, nanomedicines selectively accumulate in …